Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five‐year cancer registry review
- 1 January 1992
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 99 (1) , 54-58
- https://doi.org/10.1111/j.1471-0528.1992.tb14393.x
Abstract
ObjectiveTo review the incidence of Stage I epithelial ovarian carcinoma in the West Midlands region and to identify prognostic factors that have a significant effect on survival.DesignA retrospective review of all Stage I ovarian cancer patients registered from 1.1.80 to 31.12.84.SettingWest Midlands Regional Cancer Registry.Population457 patients with Stage I ovarian cancer—373 with epithelial ovarian carcinoma.Main outcome measuresSurvival at censor date of 30.6.89.Results28% developed recurrent disease, and the overall 50‐year survival of the group was 70%. Univariate analysis of all possible prognostic factors showed that stage, adjuvant chemotherapy, histological grade and type, surgical rupture of the tumour, intact capsule histologically, clinical finding of ascites and the performance of peritoneal washings were significantly associated with survival. Adequate surgical staging as defined by FIGO was not significantly associated with survival. A multivariate analysis based on the Cox proportional hazard model identified histological grade, adjuvant chemotherapy, patient age and peritoneal washings as having independent prognostic effects. Surprisingly adjuvant chemotherapy and peritoneal washings had negative effects on survival.ConclusionsAlthough a retrospective review has limitations, it would appear that adequate surgical staging and adjuvant chemotherapy confer no benefit in terms of survival in Stage I disease.Keywords
This publication has 9 references indexed in Scilit:
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Initial therapy for early ovarian carcinomaCancer, 1987
- A study of 656 patients with “early” ovarian cancerGynecologic Oncology, 1984
- The role of adjuvant therapy in Stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Advances in the staging and treatment of ovarian cancerCancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Factors influencing survival in Stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1973
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958